作者
Virginija Dudutiene, Jurgita Matuliene, Alexey Smirnov, David D Timm, Asta Zubriene, Lina Baranauskiene, Vaida Morkunaite, Joana Smirnoviene, Vilma Michailoviene, Vaida Juozapaitiene, Aurelija Mickeviciute, Justina Kazokaite, Sandra Baksyte, Aiste Kasiliauskaite, Jelena Jachno, Jurgita Revuckiene, Migle Kisonaite, Vilma Pilipuityte, Egle Ivanauskaite, Goda Milinaviciute, Vytautas Smirnovas, Vilma Petrikaite, Visvaldas Kairys, Vytautas Petrauskas, Povilas Norvaisas, Darius Linge, Paulius Gibieza, Edita Capkauskaite, Audrius Zaksauskas, Egidijus Kazlauskas, Elena Manakova, Saulius Grazulis, John E Ladbury, Daumantas Matulis
发表日期
2014/11/26
期刊
Journal of Medicinal Chemistry
卷号
57
期号
22
页码范围
9435-9446
出版商
American Chemical Society
简介
Human carbonic anhydrase IX (CA IX) is highly expressed in tumor tissues, and its selective inhibition provides a potential target for the treatment of numerous cancers. Development of potent, highly selective inhibitors against this target remains an unmet need in anticancer therapeutics. A series of fluorinated benzenesulfonamides with substituents on the benzene ring was designed and synthesized. Several of these exhibited a highly potent and selective inhibition profile against CA IX. Three fluorine atoms significantly increased the affinity by withdrawing electrons and lowering the pKa of the benzenesulfonamide group. The bulky ortho substituents, such as cyclooctyl or even cyclododecyl groups, fit into the hydrophobic pocket in the active site of CA IX but not CA II, as shown by the compound’s co-crystal structure with chimeric CA IX. The strongest inhibitor of recombinant human CA IX’s catalytic domain in …
引用总数
201520162017201820192020202120222023202438151523611445
学术搜索中的文章
V Dudutiene, J Matuliene, A Smirnov, DD Timm… - Journal of Medicinal Chemistry, 2014